Paper8328792
Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin.
Mor N and 1 other. Antimicrob Agents Chemother, 1993. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin. Papers, record 8328792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8328792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clarithromycin | Major topic |
| Macrophages | Major topic |
| Mycobacterium avium | Major topic |
| Cells, Cultured | |
| Humans | |
| Intracellular Fluid | |
| Kinetics | |
| Microbial Sensitivity Tests | |
| Tuberculosis |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1387302 | Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1387302 | PubMed |
| 2 | 8431006 | MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8431006 | PubMed |
| 3 | 7012004 | Preliminary demonstration of human tuberculoimmunity in vitro. | Infect Immun | 1981 | https://conductscience.org/library/papers/7012004 | PubMed |
| 4 | 3143278 | Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages. | Am Rev Respir Dis | 1988 | https://conductscience.org/library/papers/3143278 | PubMed |
| 5 | 2684005 | New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2684005 | PubMed |
| 6 | 1318761 | The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. | Ann Pharmacother | 1992 | https://conductscience.org/library/papers/1318761 | PubMed |
| 7 | 2171421 | Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2171421 | PubMed |
| 8 | 1828135 | Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1828135 | PubMed |
| 9 | 1832527 | Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. | Am Rev Respir Dis | 1991 | https://conductscience.org/library/papers/1832527 | PubMed |
| 10 | 1656860 | Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1656860 | PubMed |
| 11 | 1532486 | Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. | Am Rev Respir Dis | 1992 | https://conductscience.org/library/papers/1532486 | PubMed |
| 12 | 2530933 | In vitro and in vivo activities of clarithromycin against Mycobacterium avium. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2530933 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26819743 | Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes. | J Pharm Health Care Sci | 2015 | https://conductscience.org/library/papers/26819743 | PubMed |
| 9797242 | Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9797242 | PubMed |
| 9199452 | The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin. | Infect Immun | 1997 | https://conductscience.org/library/papers/9199452 | PubMed |
| 8593025 | Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/8593025 | PubMed |
| 7872747 | A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7872747 | PubMed |
| 7793895 | Activities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse model. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7793895 | PubMed |
| 7698125 | Animal and cell-culture models for the study of mycobacterial infections and treatment. | Eur J Clin Microbiol Infect Dis | 1994 | https://conductscience.org/library/papers/7698125 | PubMed |
| 7695255 | Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7695255 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8328792
GET https://conductscience.org/api/papers/v1/8328792/authors